NIH-funded research R01 grant

Reducing cardiovascular risk by stopping alcohol use

Official title: Reducing Cardiovascular Risks: The Role of Alcohol Use

Funded at University of Texas Arlington · NIH-11432868 · Data updated 2026-11-12

A major NIIH-funded trial will test whether abstaining from alcohol improves heart and blood vessel health in adults who drink more than recommended.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$596,443
NIH project number1R01AA033398-01
Project IDNIH-11432868 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21+ who drink beyond recommended limits but have no alcohol use disorder or existing heart disease.

Less likely to help

Individuals with alcohol use disorder, existing cardiovascular disease, or those unwilling to participate in abstinence.

What this research studies

This study will enroll adults 21 and older who drink above recommended levels but do not have alcohol use disorder or cardiovascular disease. Participants will receive a new abstinence program built around the Know-Your-Number approach and will be monitored with self-reports, biomarkers, and smartwatch data. The research uses a randomized controlled design to measure changes in blood pressure, central and peripheral vascular function, and other heart risk factors before and after abstinence. Results will help clarify whether reducing or stopping drinking can reverse or lessen cardiovascular risk.

Why it matters

Potential benefit: If successful, the trial could provide strong evidence that stopping or reducing alcohol use lowers heart disease risk and guides clinician and patient decisions.

How similar studies have gone: Previous work suggests lifestyle changes can impact cardiovascular risk, but high-quality randomized trials on abstinence are limited.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: Hwang, Chueh-Lung — University of Texas Arlington
  • Study coordinator: Hwang, Chueh-Lung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.